AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 14, Issue 9, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-09-06
DOI
10.1038/s41419-023-06092-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated bioinformatic analysis and experiment confirmation of the antagonistic effect and molecular mechanism of ginsenoside Rh2 in metastatic osteosarcoma
- (2021) Dan Liu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
- (2021) Yang Gao et al. Frontiers in Oncology
- Medical therapies for intra-hepatic cholangiocarcinoma
- (2021) Mathew Vithayathil et al. JOURNAL OF HEPATOLOGY
- Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular–clinical analysis and potential targeted approach
- (2019) Keun Soo Ahn et al. Hepatology International
- Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis
- (2019) Wei-xun Chen et al. MEDICINE
- Overexpression of the zinc-α2-glycoprotein accelerates apoptosis and inhibits growth via the mTOR/PTEN signaling pathway in gastric carcinoma cells
- (2019) Wenbo Li et al. LIFE SCIENCES
- Epithelial Mesenchymal Transition in Tumor Metastasis
- (2018) Vivek Mittal Annual Review of Pathology-Mechanisms of Disease
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma
- (2018) Masatoshi Kudo Liver Cancer
- Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma
- (2017) Stefan Buettner et al. JOURNAL OF SURGICAL ONCOLOGY
- Cholangiocarcinoma — evolving concepts and therapeutic strategies
- (2017) Sumera Rizvi et al. Nature Reviews Clinical Oncology
- Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation
- (2016) Giuliana Cavalloni et al. BMC CANCER
- AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways
- (2016) Ming-Yi Xu et al. CANCER LETTERS
- Epithelial-mesenchymal transition in tumor metastasis
- (2016) Kay T. Yeung et al. Molecular Oncology
- H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma
- (2016) Erbao Zhang et al. NUCLEIC ACIDS RESEARCH
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
- (2016) Supriya K. Saha et al. ONCOLOGIST
- Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
- (2015) J. W. Cassidy et al. CANCER RESEARCH
- Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression
- (2015) Masao Saitoh CANCER SCIENCE
- Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
- (2015) A. Moeini et al. CLINICAL CANCER RESEARCH
- Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers
- (2015) Christoph Burdelski et al. INTERNATIONAL JOURNAL OF CANCER
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
- (2014) John Bridgewater et al. JOURNAL OF HEPATOLOGY
- Computational Prediction and Analysis of Breast Cancer Targets for 6-Methyl-1, 3, 8-Trichlorodibenzofuran
- (2014) Kumaraswamy Naidu Chitrala et al. PLoS One
- Comparative Reverse Screening Approach to Identify Potential Anti-neoplastic Targets of Saffron Functional Components and Binding Mode
- (2013) Biplab Bhattacharjee et al. Asian Pacific Journal of Cancer Prevention
- Identification of Proapoptopic, Anti-Inflammatory, Anti-Proliferative, Anti-Invasive and Anti-Angiogenic Targets of Essential Oils in Cardamom by Dual Reverse Virtual Screening and Binding Pose Analysis
- (2013) Biplab Bhattacharjee et al. Asian Pacific Journal of Cancer Prevention
- Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients
- (2013) Dengbo Ji et al. CARCINOGENESIS
- Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma
- (2013) Laurent Sulpice et al. HEPATOLOGY
- Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma
- (2013) Toshima Z. Parris et al. INTERNATIONAL JOURNAL OF CANCER
- Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer
- (2013) Chun-yu Huang et al. PLoS One
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma
- (2012) Naoki Oishi et al. HEPATOLOGY
- Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis
- (2012) Yan Huang et al. Journal of Translational Medicine
- Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells
- (2012) Magdalena Ksiazkiewicz et al. PATHOBIOLOGY
- A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment
- (2012) Xiuxiu Li et al. PLoS One
- Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer
- (2011) Po Yee Yip et al. PROSTATE
- AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma
- (2010) Daniel L. Albertus et al. Journal of Thoracic Oncology
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling
- (2010) B Kong et al. ONCOGENE
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
- (2009) James E. Everhart et al. GASTROENTEROLOGY
- Zinc 2-Glycoprotein: A Multidisciplinary Protein
- (2008) Md. I. Hassan et al. MOLECULAR CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started